Sign inJoin waitlistJoin the waitlist

Christian Grommes

Specialist · New York Presbyterian Hospital

Credentials: · · · · ·

History

New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
2008–2009
Neurology
Case Western Reserve University/University Hospitals Cleveland Medical Center
2004–2008
RHEINISCH-WESTFALISCHE TECH HOCH AACHEN, MED FAK, AACHEN, GERMANY
1996–2000

Research

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Science · 2013 · 974 citations
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Nature · 2019 · 519 citations
Primary CNS Lymphoma
Review · Journal of Clinical Oncology · 2017 · First of 2 authors · 491 citations

LS
Lauren Schaff
29 papers
LD
Lisa DeAngelis
27 papers
IM
Ingo Mellinghoff
21 papers
Elena Pentsova
19 papers
TK
Thomas Kaley
16 papers
Igor Gavrilovic
15 papers
RY
Robert Young
14 papers
Antonio Omuro
11 papers
CN
Craig Nolan
11 papers
MR
Marc Rosenblum
11 papers
JS
Jacqueline Stone
9 papers
AL
Andrew Lin
8 papers

Clinical trials

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2025–2028
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2020–2026
Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2019–2026
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2018–2026